Literature DB >> 23975590

Laparoscopic antireflux surgery improves esophageal body motility in patients with severe reflux esophagitis.

Natsuya Katada1, Hiromitsu Moriya, Keishi Yamashita, Kei Hosoda, Shinichi Sakuramoto, Shiro Kikuchi, Masahiko Watanabe.   

Abstract

PURPOSE: This study was designed to clarify whether laparoscopic antireflux surgery (LARS) improves the esophageal body motility (EBM) in patients with reflux esophagitis.
METHODS: Thirty-five patients with gastroesophageal reflux disease (GERD) scheduled to undergo LARS were divided into a mild esophagitis group (ME; n = 18, Grade O:A:B = 7:10:1) and a severe esophagitis group (SE; n = 17, Grade C:D = 13:4), according to the Los Angeles classification of reflux esophagitis. The types of fundoplication (Nissen/Toupet) were 6/12 in the ME group and 4/13 in the SE group. Esophageal pH monitoring and manometry were performed before and 1 year after surgery.
RESULTS: The fraction time of a pH below 4 significantly decreased after surgery in both groups. The LES pressures did not change significantly after surgery in the ME group, but significantly increased in the SE group. The peristaltic amplitudes 18 and 13 cm above the LES did not change significantly after surgery in either group. The peristaltic amplitudes 8 and 3 cm above the LES did not change significantly after surgery in the ME group, but significantly increased after surgery in the SE group.
CONCLUSIONS: The preoperative EBM was not improved by LARS in patients with GERD and mild mucosal breaks in the esophagus, but the preoperative middle to distal EBM was improved by LARS in patients with GERD and severe mucosal breaks.

Entities:  

Mesh:

Year:  2013        PMID: 23975590     DOI: 10.1007/s00595-013-0704-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  27 in total

1.  Proton pump inhibitors or surgery for gastro-oesophageal reflux disease.

Authors:  R A Hinder
Journal:  Dig Liver Dis       Date:  2002-02       Impact factor: 4.088

2.  Early experience with single-incision laparoscopic Nissen fundoplication for gastroesophageal reflux disease in patients with mental retardation via a gastrostomy site incision: report of five cases.

Authors:  Masaru Mizuno; Megumi Kobayashi; Akira Sasaki; Jun Nakajima; Go Wakabayashi
Journal:  Surg Today       Date:  2012-01-26       Impact factor: 2.549

3.  Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Yoko Watanabe; Masatsugu Shiba; Toshio Watanabe; Kazunari Tominaga; Nobuhide Oshitani; Takayuki Matsumoto; Hideki Nishikawa; Tetsuo Arakawa
Journal:  J Gastroenterol Hepatol       Date:  2005-01       Impact factor: 4.029

4.  Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease.

Authors:  G M Campos; S R DeMeester; J H Peters; S Oberg; P F Crookes; J A Hagen; C G Bremner; L F Sillin; R J Mason; T R DeMeester
Journal:  Arch Surg       Date:  2001-11

5.  Nissen vs Toupet laparoscopic fundoplication.

Authors:  C Zornig; U Strate; C Fibbe; A Emmermann; P Layer
Journal:  Surg Endosc       Date:  2002-02-08       Impact factor: 4.584

6.  Laparoscopic Heller myotomy with Toupet fundoplication for achalasia straightens the esophagus and relieves dysphagia.

Authors:  Natsuya Katada; Shinichi Sakuramoto; Nobuyuki Kobayashi; Nobue Futawatari; Shinichi Kuroyama; Shiro Kikuchi; Masahiko Watanabe
Journal:  Am J Surg       Date:  2006-07       Impact factor: 2.565

7.  Fundoplication improves disordered esophageal motility.

Authors:  T Ryan Heider; Kevin E Behrns; Mark J Koruda; Nicholas J Shaheen; Tananchai A Lucktong; Barbara Bradshaw; Timothy M Farrell
Journal:  J Gastrointest Surg       Date:  2003-02       Impact factor: 3.452

8.  Laparoscopic surgery for gastroesophageal reflux disease patients with impaired esophageal peristalsis: total or partial fundoplication?

Authors:  Emmanuel Chrysos; John Tsiaoussis; Odysseus John Zoras; Elias Athanasakis; Apostolos Mantides; Asterios Katsamouris; Evaghelos Xynos
Journal:  J Am Coll Surg       Date:  2003-07       Impact factor: 6.113

Review 9.  Evidence-based appraisal of antireflux fundoplication.

Authors:  Marco Catarci; Paolo Gentileschi; Claudio Papi; Alessandro Carrara; Renato Marrese; Achille Lucio Gaspari; Giovanni Battista Grassi
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

10.  Laparoscopic Toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility.

Authors:  R J Lund; G J Wetcher; F Raiser; K Glaser; G Perdikis; M Gadenstätter; N Katada; C J Filipi; R A Hinder
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

View more
  4 in total

1.  Comparison of laparoscopic Nissen and Toupet fundoplication using a propensity score matching analysis.

Authors:  Masato Hoshino; Nobuo Omura; Fumiaki Yano; Kazuto Tsuboi; Se Ryung Yamamoto; Shunsuke Akimoto; Norio Mitsumori; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2017-03-01       Impact factor: 2.549

2.  LATE EVALUATION OF PATIENTS OPERATED FOR GASTROESOPHAGEAL REFLUX DISEASE BY NISSEN FUNDOPLICATION.

Authors:  Maxwel Capsy Boga Ribeiro; Amanda Bueno de Araújo; Juverson Alves Terra-Júnior; Eduardo Crema; Nelson Adami Andreollo
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep

3.  Surgical results of laparoscopic Toupet fundoplication for gastroesophageal reflux disease with special reference to recurrence.

Authors:  Nobuo Omura; Fumiaki Yano; Kazuto Tsuboi; Masato Hoshino; SeRyung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Esophagus       Date:  2018-04-27       Impact factor: 4.230

4.  Impact of reflux esophagitis on the esophageal function before and after laparoscopic fundoplication.

Authors:  Masato Hoshino; Nobuo Omura; Fumiaki Yano; Kazuto Tsuboi; Se Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Esophagus       Date:  2018-04-26       Impact factor: 4.230

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.